Photo: Ctorrear ( talk ), CC0, via Wikimedia Commons⁹

Pablo DT Valenzuela

Chilean biochemist

Pablo Valenzuela (Latin American Spanish: [ˈpaβlo βalenˈswela]; born June 13, 1941) is a Chilean biochemist dedicated to biotechnology development. He is known for his genetic studies of hepatitis viruses; participated as a research and development director in the discovery of hepatitis C virus and the invention of the world's first recombinant vaccine (against hepatitis B virus).²

From Wikipedia’s article on Pablo DT Valenzuela (this version), CC BY-SA 4.0.

Born Jun 13, 1941.¹

About

He is one of the cofounders of the biotechnology company Chiron Corporation and of Fundacion Ciencia para la Vida, a private non profit institution where he is currently working.

From Wikipedia’s article on Pablo DT Valenzuela, shared under CC BY-SA 4.0.²

Companies

Chiron CorporationFounder⁸

Early life and education

Date not recordedUniversity of California, San Francisco³
Date not recordedUniversity of Chile³

Career

Occupation: businessperson, biochemist.⁵

Date not recordedFounded Chiron Corporation⁴

Valenzuela has been responsible for the development of biotechnology products in the USA and Chile in the area of international diagnostics, blood banking and pharmaceuticals. He is a cofounder responsible for the early activities of biotechnology start-ups in the USA and Chile. He is also a professor and investigator in graduate programs, generating scientific publications and patents.

Valenzuela was recipient of the Chilean National Prize for Applied Sciences and Technologies in 2002 and is a member of the Chilean Academy of Sciences. He was awarded the UCSF medal in 2014.

Science & technology developments in USA

Cofounder of Chiron Corporation.

Ten products in the field of international diagnostics and blood banking (Hepatitis C, AIDS, Hepatitis B) that have been commercialized by Chiron Corporation, Abbott and Johnson & Johnson.

Four products in the pharmaceutical field (Hepatitis B vaccine, human insulin, beta-interferon and a wound healing gel based on PDGF) and one product for the food industry (bovine rennin), commercialized worldwide by Chr. Hansen.

Science & technology developments in Chile

Co-founder and president of Bios Chile and Austral Biologicals.

Co-founder and director of Fundación Ciencia para la Vida.

Co-founder and president of Andes Biotechnologies (start-up 2009).

Biotechnology products, like vaccines for the salmon aquiculture, licensed to Novartis.

Products for human health and blood banking (Chagas, H. pylori, rotavirus, blood tests).

Director of the Millennium Institute for Fundamental and Applied Biology, one of 15 centers of excellence in Chile.

From Wikipedia’s article on Pablo DT Valenzuela (this version), CC BY-SA 4.0.

Personal life

BornJun 13, 1941, Santiago⁶
CitizenshipChile⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataPablo DT Valenzuela on Wikidata
2
WikipediaPablo DT Valenzuela on Wikipedia
3
WikidataPablo DT Valenzuela: education, on Wikidata
4
WikidataPablo DT Valenzuela: Founded Chiron Corporation, on Wikidata
5
WikidataPablo DT Valenzuela: occupation, on Wikidata
6
WikidataPablo DT Valenzuela: place of birth, on Wikidata
7
WikidataPablo DT Valenzuela: citizenship, on Wikidata
8
WikidataChiron Corporation, Founder
9
Wikimedia CommonsPablo DT Valenzuela photo by Ctorrear ( talk ), CC0